There is such a vaccine, but it is still under development. According to reports, the vaccine is called Yi Ke.
Bigram is an immunogenic antigen-antibody complex composed of recombinant hepatitis B surface antigen and human anti-hepatitis B high-potency immunoglobulin in accordance with patent regulations. It has been under the National High-tech 863 Program since 1987. The innovative products with my country's independent intellectual property rights developed with the support are now funded by the "10th Five-Year Plan" National Major Science and Technology Project. They have participated in the "15th Anniversary" exhibition of the National 863 Program and received awards from the program.
This product has been studied in ducks and hepatitis B surface antigen-positive transgenic mice, and compared with synthetic peptides, simple hepatitis B antigen, and DNA vaccines encoding the S gene. The results prove that the immunogenicity of the compound It can make animals produce antibodies and cellular immunity, and has the best effect in clearing antigens.
In 1999, it cooperated with the Beijing Institute of Biological Products for research and development. Without precedent at home and abroad, it researched and formulated the production process and entered industrialization.
Some participants had no feeling except for a slight swelling and pain in their arms during the injection (I don’t know if it was a placebo). They also took the medicine Feipiao and liver-protecting tablets, and wrote in a diary.
How to participate in clinical research as a clinical volunteer?
The research plan is expected to involve about 240 people, but one-third of them will be placebo injections, because there must be a double-blind control for the results to be scientific. However, once the blindness is lifted, patients who receive the placebo injection will immediately have the right to receive the full course of treatment with the Etg injection. Each participant must also undergo systematic laboratory tests and physical examinations, and must rule out contraindications before being included in the group. The program will be carried out in selected hospitals, not only in Beijing, but also in Shanghai, Hangzhou and other cities. Once the clinical research plan and participating units are determined, they will be announced as soon as possible. Patients who are willing to participate can contact the nearest hospital. Those who meet the clinical trial conditions can be enrolled at the relevant hospital after signing the informed consent form.
Beijing Ditan Hospital and You'an Hospital may be Yike's selected hospitals.
Animal test results show that the vaccine can clear the virus in animals, which means it is possible to turn the human hepatitis virus from positive to negative.
Whether or not the vaccine developed by the Third Military Medical University that can convert hepatitis B virus carriers into hepatitis B virus carriers is similar to what you mentioned above, I hope your body will get better as soon as possible!
Because, I am also paying attention to it like you!